Primary study · included by 1 review
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study.
Ballal 2023 · Ballal Sanjana, Yadav Madhav P, Satapathy Swayamjeet, et al. · European journal of nuclear medicine and molecular imaging · 2023
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.